Prairie Education and Research Cooperative
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1983-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)HFpEF and Symptomatic Obstructive Iliofemoral Venous Disease Study
Terminated
- Conditions
- Heart Failure With Preserved Ejection FractionVenous Disease
- First Posted Date
- 2021-07-16
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Prairie Education and Research Cooperative
- Target Recruit Count
- 3
- Registration Number
- NCT04964817
- Locations
- 🇺🇸
Prairie Heart Institute at St. Johns Hospital, Springfield, Illinois, United States
A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
Not Applicable
Terminated
- Conditions
- Deep Vein ThrombosisCoronary Artery Bypass SurgeryVenous Thromboembolism
- Interventions
- Other: Placebo
- First Posted Date
- 2008-11-11
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- Prairie Education and Research Cooperative
- Target Recruit Count
- 78
- Registration Number
- NCT00789399
News
No news found